Palmoplantar pustulosis successfully treated with upadacitinib: Report of three cases

Australasian Journal of DermatologyEarly View CLINICAL LETTER Palmoplantar pustulosis successfully treated with upadacitinib: Report of three cases Francesca Maria Gaiani MD, Corresponding Author Francesca Maria Gaiani MD [email protected] orcid.org/0009-0003-7613-4451 Department of Dermatology, IRCCS Policlinico San Donato, San Donato Milanese (MI), Italy Correspondence Francesca Maria Gaiani, Department of Dermatology, IRCCS Policlinico San Donato, San Donato Milanese (MI), Italy. Email: [email protected]Search for more papers by this authorPiergiorgio Malagoli MD, Piergiorgio Malagoli MD Department of Dermatology, IRCCS Policlinico San Donato, San Donato Milanese (MI), ItalySearch for more papers by this authorCarlo Giovanni Carrera MD, Carlo Giovanni Carrera MD Department of Dermatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan (MI), ItalySearch for more papers by this author Francesca Maria Gaiani MD, Corresponding Author Francesca Maria Gaiani MD [email protected] orcid.org/0009-0003-7613-4451 Department of Dermatology, IRCCS Policlinico San Donato, San Donato Milanese (MI), Italy Correspondence Francesca Maria Gaiani, Department of Dermatology, IRCCS Policlinico San Donato, San Donato Milanese (MI), Italy. Email: [email protected]Search for more papers by this authorPiergiorgio Malagoli MD, Piergiorgio Malagoli MD Department of Dermatology, IRCCS Policlinico San Donato, San Donato Milanese (MI), ItalySearch for more papers by this authorCarlo Giovanni Carrera MD, Carlo Giovanni Carrera MD Department of Dermatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan (MI), ItalySearch for more papers by this author First published: 21 August 2023 https://doi.org/10.1111/ajd.14142Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Mohr J, Rahbar Kooybaran N, Schön MP, Mössner R. Response of palmoplantar pustulosis to upadacitinib. J Dtsch Dermatol Ges. 2023; 21: 280–282. https://doi.org/10.1111/ddg.14969 2Mössner R, Hoff P, Mohr J, Wilsmann-Theis D. Successful therapy of palmoplantar pustulosis with tofacitinib-report on three cases. Dermatol Ther. 2020; 33:e13753. https://doi.org/10.1111/dth.13753 3Avallone G, Maronese CA, Murgia G, Carrera CG, Mastorino L, Roccuzzo G, et al. Interleukin-17 vs. Interleukin-23 inhibitors in pustular and Erythrodermic psoriasis: a retrospective, multicentre cohort study. J Clin Med. 2023; 12(4):1662. https://doi.org/10.3390/jcm12041662 4Genovese G, Moltrasio C, Cassano N, Maronese CA, Vena GA, Marzano AV. Pustular psoriasis: from pathophysiology to treatment. Biomedicine. 2021; 9(12): 1746. https://doi.org/10.3390/biomedicines9121746 5McCluskey D, Benzian-Olsson N, Mahil SK, Hassi NK, Wohnhaas CT, APRICOT and PLUM study team, et al. Single-cell analysis implicates TH17-to-TH2 cell plasticity in the pathogenesis of palmoplantar pustulosis. J Allergy Clin Immunol. 2022; 150(4): 882–893. https://doi.org/10.1016/j.jaci.2022.04.027 Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation